Insulin-like growth factor II activates mitogenic signaling in pancreatic cancer cells via IRS-1: In vivo evidence for an islet-cancer cell axis

International Journal of Oncology

Volumn 9, Issue 3, 1996, Pages 487-492

  Bergmann, Uwe ^a   Funatomi, Hitoshi ^a   Kornmann, Marko ^a   Ishiwata, Toshiyuki ^a   Beger, Hans G ^b   Korc, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

IGF I; IGF II; IRS 1; pancreatic cancer

Indexed keywords

MONOCLONAL ANTIBODY; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR;

ARTICLE; CANCER GROWTH; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; MITOGENESIS; PANCREAS CANCER; PANCREAS ISLET CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA TRANSCRIPTION;

EID: 0029788198     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Silverberg E and Lubera JA: Cancer statistics. CA Cancer J Clin 3: 3-39, 1989.
2. Gudjonsson B: Cancer of the pancreas. 50 years of surgery. Cancer 60: 2284-2303, 1987.
3. Bos JL: Ras oncogenes in human cancer: A review. Cancer Res 49: 4682-4689, 1989.
4. Barton CM, Staddon SL, Hughes CM, Hall PA, O'Sullivan C, Kloppel G, Theis B, Russel RCG, Neoptolemos J, Williamson RCN, Lane DP and Lemoine NR: Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer 64: 1076-1082, 1991.
5. Casey G, Yamanaka Y, Friess H, Kobrin MS, Lopez ME, Buchler M, Beger HG and Korc M: p53 mutations are common in pancreatic cancer and absent in chronic pancreatitis. Cancer Lett 69: 151-160, 1992.
6. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Buchler M and Beger HG: Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor a. J Clin Invest 90: 1352-1360, 1992.
7. Kobrin MS, Funatomi H, Friess H, Buchler MW, Stathis P and Korc M: Induction and expression of heparin-binding EGF-Iike growth factor in human pancreatic cancer. Biochem Biophys Res Commun 202: 1705-1709, 1994.
8. Ebert M, Yokoyama M, Kobrin MS, Friess H, Lopez ME, Buchler MW, Johnson GR and Korc M: Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res 54: 3959-3962, 1994.
9. Yokoyama M, Funatomi H, Kobrin MS, Ebert M, Friess H, Buchler MW and Korc M: Betacellulin, a member of the epidermal growth factor family, is overexpressed in human pancreatic cancer. Int J Oncol 7: 825-829, 1995.
10. Yamanaka Y, Friess H, Buchler M, Beger HG, Uchida E, Onda M, Kobrin MS and Korc M: Overexpression of acidic and basic fibroblast growth factors I in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 53: 5289-5296, 1993.
11. Friess H, Yamanaka Y, Buchler M, Ebert M, Beger HG, Gold LI and Korc M: Enhanced expression of transforming growth factor ß isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105: 1846-1856, 1993.
12. Ebert M, Yokoyama M, Friess H, Buchler MW and Korc M: Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 54: 5775-5778, 1994.
13. Di Renzo MF, Poulsom R, Olivero M, Comoglio PM and Lemoine NR: Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 55: 1129-1138, 1995.
14. Ebert M, Yokoyama M, Friess H, Kobrin MS, Buchler MW and Korc M: Induction of platelet-derived growth factor α and ß chains and over-expression of their receptors in human pancreatic cancer. Int J Cancer 62: 529-535, 1995.
15. Bergmann U, Funatomi H, Yokoyama M, Beger HG and Korc M: Insulin-like growth factor I overexpression in human pancreatic cancer: Evidence for autocrine and paracrine roles. Cancer Res 55: 2007-2011, 1995.
16. Daughaday WH and Rotwein P: Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrine Rev 10: 68-91, 1989.
17. Frosch RG, Busby WH and Schwander J: Actions of insulin-like growth factors. Annu Rev Physiol 47: 443-467, 1985.
18. Nissley P, Kiess W and Sklar MM: The insulin-like growth factor II/mannose 6-phosphate receptor. In: Insulin-Like Growth Factors: Molecular and Cellular Aspects. LeRoith (ed). CRC Press, Boca Raton, pp111-150, 1991.
19. Daughaday WH: Editorial: The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 127: 1-4, 1990.
20. Macaulay VM: Insulin-like growth factors and cancer. Br J Cancer 65: 311-320, 1992.
21. Hermanek P and Sobin LH: TNM classification of malignant tumours. In: UICC, International Union Against Cancer. Springer-Verlag, New York, pp65-68, 1987.
22. Dull TH, Gray A, Hayflick JS and Ulrich A: Insulin-like growth factor II precursor gene organization in relation to insulin gene family. Nature 310: 777-781, 1984.
23. Feinberg AP and Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13, 1983.
24. Mossmann PB and Young LL: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 49-53, 1983.
25. Raitano AB, Scuderi P and Korc M: Binding and biological effects of tumor necrosis factor and γ interferon in human pancreatic carcinoma cells. Pancreas 5: 267-277, 1990.
26. Shi SR, Key ME and Kalra KL: Antigen retrieval in formalin-fixed, paraffin embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991.
27. Reeve AE, Eccles MR, Wilkins RJ, Bell GI and Millow LJ: Expression of insulin-like growth factor-11 transcripts in Wilms' tumor and embryonic tissues. Nature 317: 258-260, 1985.
28. Raile K, Hoflich A, Kessler U, Yang Y, Pfuendner M, Blum WF, KoIb H, Schwarz HP and Kiess W: Human osteosarcoma (U-2 OS) cells express both Insulin-like growth factor-I (IGF-I) receptors and Insulin-like growth factor-II/mannose 6-phosphate (IGF-II/1V16P) receptors and synthesize IGF-II: Autocrine growth stimulation by IGF-II via IGF-IR. J Cell Physiol 159: 531-541, 1994.
29. El-Badry OM: Insulin-like growth factor II gene expression in human neuroblastpma. Prog Clin Biol Res 366: 249-256, 1991.
30. Singh P and Rubin N: Insulin-like growth factors and binding proteins in colon cancer. Gastroenterology 105: 1218-1237, 1993.
31. Livesmaki V, Kahri Al, Miettinen PJ and Voutilainen R: Insulin-like growth factors (IGFs) and their receptors in adrenal tumors, high IGF-II expression in functional adrenocortical carcinomas. J Clin Endocrinol Metabol 77: 852-858, 1993.
32. Quinn KA, Treston AM, Unsworth EJ, Miller M-J, Vos M, Grimley C, Battey J, Mulshine JL and Cuttita F: Insulin-like growth factor expression in human cancer cell lines. J Biol Chem 271: 11477-11483, 1996.
33. Zapf J: Role of insulin-like growth factor II and IGF binding proteins in extrapancreatic tumor hypoglycemia. Horm Res 42: 20-26, 1994.
34. Henderson JR and Daniel PM: A comparative study of the portal vessels connecting the endocrine and exocrine pancreas, with a discussion of some functional implications. Quart J Exp Physiol Cog Med Sciences 64: 267-275, 1979.
35. Bonner-Weir S: The microcirculation of the islet of Langerhans. In: The Endocrine Pancreas. Samols E (ed). Raven, New York, 1994.
36. Christofori G, Naik P and Hanahan D: A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369: 414-418, 1994.
37. Yoshida T and Hanahan D: Murine pancreatic ductal adenocarcinoma produced by in vitro transduction of polyoma middle T oncogene into the islets of Langerhans. Am J Pathol 145: 671-684, 1994.
38. Stewart CEH and Rotwein P: Insulin-like growth factor-II is and autocrine survival factor for differentiating myoblasts. J Biol Chem 271: 11330-11338, 1996.
39. Bergmann U, Funatomi H, Kommann M, Beger HG and Korc M: Increased expression of insulin receptor substrate-1 in human pancreatic cancer. Biochem Biophys Res Commum 220: 886-890, 1996.